Book a free demo with us
Book Now
INNOVENTRIC
Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Innoventric is committed to expanding treatment beyond the traditionally treated patient population, extending care to the overlooked, ‘still forgotten’ patient population.
Total Fundraised$5B
PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
2017
Ness Ziona, Israel
ISR
USA
Healthcare
Health Care
Medical
Medical Device
Clinical Trials
- 
https://innoventric.com/Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
INNOVENTRIC's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
Social Media
© 2024 Lucidity Insights.
